MarketLens

Why is Thermo Fisher Betting Big on Clinical Trial Data

5 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Thermo Fisher's Executive Sales: A Calculated Monetization Amidst Strong Performance

4 weeks ago

Why Wall Street Is Betting Big on $5,000 Gold

8 months ago

Thermo Fisher Scientific's C-Suite Selling Tests a Fully-Priced Growth Story

2 weeks ago

Why Are Lawmakers Betting Big on Citigroup

4 months ago

Care Management Solutions Market worth $42.62 billion by 2031 - Exclusive Report by MarketsandMarkets™

Care management solutions market is projected to reach $42.62B by 2031, up from $22.56B in 2024, per MarketsandMarkets. Growth reflects rising demand for value-based care and digital health tools.

Stock News•3 weeks ago

How Thermo Fisher Is Riding Bioproduction and AI-Led Growth Trends

Thermo Fisher is expanding bioproduction, AI tools, and clinical data capabilities to drive growth, though execution remains key amid intensifying competition.

TMO

Stock News•1 months ago

NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner

NetraMark signed a new contract to analyze a Phase 2 neurodegeneration trial dataset through its CRO partner, marking its first CRO-sourced deal and expanding its AI-driven CNS portfolio.

AIAI

Stock News•1 months ago

EDETEK to Support the FDA's Real-Time Clinical Trials Initiative with Its R&D Cloud and Sponsor Partnership Program

EDETEK launched a sponsor partnership program to help life sciences firms prepare for the FDA's Real-Time Clinical Trials Initiative, leveraging its R&D Cloud platform.